Advanced
Products
Solutions
Partners
Resources
Company
Toggle menu
Home
/
ImmPACT-Bio
ImmPACT-Bio
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
ImmPACT-Bio
Total Funding
$18 M
ImmPACT-Bio Summary
Company summary
Overview
ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy. Its technology addresses the need to differentiate cancerous from non-cancerous tissues with a special focus on a common mechanism for tumor immune-escape.
Type
Private
Status
Active
Founded
2017
HQ
Camarillo, CA, US
|
view all locations
Website
https://immpact-bio.com/
Cybersecurity rating
Sectors
Healthcare
biotech
oncology
therapy
Homepage
Linkedin
Locations
View all
2 locations detected
Camarillo, CA
HQ
United States
4010 Adolfo Rd
Rishon LeTsiyon, Center District
Israel
Bergman St, Rishon LeTsiyon
Report incorrect company information
Competitors and similar companies
Neovii
Healthcare - Private
JW Therapeutics
Healthcare - Private
Alpha Tau Medical
Healthcare - Private
Reflexion Medical
Healthcare - Private
Compare competitors
News
ImmPACT Bio USA Inc. Raises $18 Million In Series A Financing
Aug 18, 2020
Report incorrect company information
Footer menu
Contact us
Facebook
Twitter
LinkedIn
Products
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Press
Company
About
Careers
Terms of Service
Privacy Policy
© Craft.co 2023
Share price data provided by IEX
Company directory
Search directory
Back
to top